Evaluation of Amphotericin B in the Treatment of Biopsy Proven Candida Esophagitis in Immunocompromised Patients
NCT00002041
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
INDUSTRY
Sponsor class
Conditions
Candidiasis, Esophageal
HIV Infections
Interventions
DRUG:
Amphotericin B
Sponsor
Bristol-Myers Squibb